The new exoskeleton technology combines biomechanics, sensors, and patient feedback to support gait training and ...

Patients with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, live an average of only three years after ...

PRESS RELEASEAB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIODFinancial and ...

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

VATICAN: Pope Leo XIV on Friday morning welcomed members of the Italian Association for Amyotrophic Lateral Sclerosis (AISLA) ...

By Rocky Swift TOKYO, May 14 (Reuters) - Bain Capital-owned Tanabe Pharma plans to bring up to three new drugs to Japan each year as the former Mitsubishi Chemical unit doubles down on its home market ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

The core facilities of the Cibio Department of the University of Trento have all taken part in a study on amyotrophic lateral ...

Primary lateral sclerosis (PLS) is a rare, progressive condition that affects upper motor neurons, leading to stiffness, spasticity, and mobility challenges. While there’s no cure, symptom-focused ...

The FDA has granted Fast Track designation to tazbentetol for the treatment of amyotrophic lateral sclerosis (ALS).

IRVINE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today reported its first quarter 2026 operating and financial results and provided recent ...

On Friday, May 15, Dutch Bros will hold its annual Drink One for Dane Day of Giving, remembering co-founder Dane Boersma and raising awareness for Amyotrophic Lateral Sclerosis (ALS). During the event ...